Jci_page_head_homepage_01 Jci_page_head_homepage_02
Enrique Zudaire, Natalia Cuesta, Vundavalli Murty, Karen Woodson, Lisa Adams, Nieves Gonzalez, Alfredo Martínez, Gopeshwar Narayan, Ilan Kirsch, Wilbur Franklin, Fred Hirsch, Michael Birrer, Frank Cuttitta
Published in Volume 118, Issue 2
J Clin Invest. 2008; 118(2):640–650 doi:10.1172/JCI30024
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5
Working model of the tumor suppression mechanism for AHRR integrated in a gene regulation feedback loop with AHR.

(A) In normal cells, activation of AHR causes induction of AHRR through XREs present in its promoter. AHRR acts as a negative regulator of AHR by competing for binding to ARNT and XREs present in the promoter regulatory region of variety of genes. The balanced relationship between the positive and negative transactivation signals of AHR and AHRR results in cellular homeostasis. (B) In cancer cells, methylation of the AHRR promoter and LOH cause blockade of its expression despite the higher levels of AHR. Thus absence of AHRR eliminates competition for binding to ARNT and XREs, which results in an imbalance between positive and negative transactivation signals, thereby causing the induction of a battery of genes related to tumorigenesis and cancer progression.